T he epidermal growth factor receptor (EGFR) family consists of 4 related tyrosine kinase receptors: EGFR (ErbB1), HER2 (ErbB2, with no ligand described), HER3 (ErbB3, without kinase function), and HER4 (ErB4). 1, 2 There are more than 10 ligands for these receptors with different specificities. 3 On ligand binding, the receptors undergo dimerization, leading to Tyr phosphorylation of the cytosolic domain and subsequent activation of various signaling pathways, including mitogen-activated protein kinases (extracellular signal-regulated kinase 1/2 [ERK1/2], p38, c-Jun N-terminal kinase), protein kinase B, c-Src kinase, and phospholipase C ␥, which affect extra-and intranuclear events. 4 Activation includes formation of homo-and heterodimers, with the EGFR possessing the ability to interact with all 3 family members. Activated ErbB receptors regulate various aspects of cell fate, such as proliferation, survival, differentiation, migration, and matrix homeostasis. 5 EGFR (ErbB1) dimers can be activated by epidermal growth factor (EGF), transforming growth factor-␣, amphiregulin, heparin-binding (HB)-EGF, ␤-cellulin, and epiregulin. ErbB1/ErbB4-dimers can be activated by neuregulins. 6 The ligands may derive from neighboring cells (paracrine) or from the same cell (autocrine), as in the case of shedding of membrane-bound pro-HB-EGF. 1 As pro-HB-EGF shedding can also be induced by activation of other receptors (eg, G-protein-coupled receptors), EGFR is subject to activation by other hormones, a mechanism called transactivation. 7 In addition, transactivation can also be achieved by intracellular pathways, involving c-Src-mediated EGFR phosphorylation. 8 Thus, EGFR, via transactivation, has the potential to mediate signaling of non-EGFR ligands and thereby serve as a heterologous transducer of cellular signaling. This mechanism has been proposed for the ERK1/2-activating action of a variety of hormones also in vascular smooth muscle cells (VSMC). 6, 9 Pathophysiological effects of EGFR include cell transformation and tumorigenesis, as well as parainflammatory dysregulation of tissue homeostasis, leading, for example, to vascular dysfunction and fibrosis. 6 There are several reports suggesting that EGFR transactivation is responsible for Gprotein-coupled receptor-mediated ERK1/2 phosphorylation (eg, induced by angiotensin II [ang II], 10,11 ␣ 1 -and ␤-adrenergic agonists, 12, 13 thrombin, 14 endothelin-1 [ET-1], [15] [16] [17] and purinergic receptor ligands 18 ) and the resulting pathophysiological effects on VSMC and vascular function, including atherosclerosis. 6 However, other hormones also, such as steroids 19 or prostaglandins 20 as well as reactive oxygen species 21 and cardiotonic steroids, 22 (mis)use the EGFR as signal transducer.
EGFR supports fibrosis in cardiovascular and renal tissue. 15, 23, 24 The importance of EGFR in mediating pathophysiological effects of heterologous signaling systems is supported by its role in endothelin-induced fibrogenic effects. 15 Endothelin-induced phosphorylation of the mitogen-activated protein kinase and endothelin-induced increase in collagen I gene activity were completely prevented by an inhibitor of the EGFR kinase. Ang II also "uses" the EGFR to elicit certain effect in cardiovascular cells. For example, Bokemeyer et al reported that ang II-induced growth of VSMC requires activation of EGFR, 25 and Mazak et al showed that ang II-or aldosterone-induced stimulation of ERK1/2 in VSMC depends on EGFR. 19 In cardiomyocytes, ang II receptor type 1A promotes hypertrophy via transactivation of the EGFR, 10, 26, 27 thus proving that EGFR serves as a heterologous transducer for pathological vascular signals such as ET-1, ang II, and catecholamines, all of which have been linked to vascular remodeling. 1 EGFR affects not only protein kinases and transcription factors but also influences cellular Ca 2ϩ signaling via phosopholipase C␥. 28, 29 Phosopholipase C␥ can induce inositoltrisphosphate-mediated Ca 2ϩ release and also Ca 2ϩ influx across the cell membrane. 30 This effect is elicited by, eg, cAMP, arachidonic acid metabolites, or internal store depletion. 31, 32 Additionally, EGFR kinase activity may also contribute to or support the Ca 2ϩ response to other mediators after transactivation. For ang II and ET-1, a small contribution of EGFR to Ca 2ϩ signaling in VSMC has been suggested on the basis of pharmacological data. 17, 33 Thus, EGFR is not only relevant for mitogen-activated protein kinase but also for Ca 2ϩ signaling. Most of the studies that have been performed relied on pharmacological or immunologic tools to unveil the contribution of EGFR to the aforementioned deleterious effects on vascular tissue homeostasis. Our work, presented here, aims at testing the hypothesis of EGFR as a heterologous signal transducer in VSMC using the genetic model of targeted EGFR deletion. We generated mice with deletion of EGFR in VSMC (EGFR ⌬/⌬ VSMC ) and compared the cells in primary culture with cells derived from wild-type littermates (EGFR ϩ/ϩ VSMC ), with respect to ERK1/2 phosphorylation, Ca 2ϩ homeostasis, and cell survival.
Methods
Generation of EGFR ⌬/⌬ VSMC Mice C57BL/6 mice containing floxed EGFR alleles (EGFR f/f ) after removal of the neo cassette were obtained from Dr M. Sibilia (University of Vienna) and used for further breeding. 34 EGFR was inactivated tissue specifically in smooth muscle cells by using SM22-cre transgenic mice, in which the cyclization recombination recombinase is under the control of the smooth muscle cell-specific SM22 promoter. 35 Genotyping of the mice was performed on tail biopsies by polymerase chain reaction (PCR) against the floxed EGFR allele as well as cyclization recombination. Mice were kept in the facilities of the University of Halle-Wittenberg in accordance with institutional policies and federal guidelines.
Cell Culture
Primary culture of VSMC from 4-to 5-month-old mice (EGFR
EGFR
ϩ/ϩ VSMC 3 VSMC EGFRϩ/ϩ ) was performed as described by Ray et al. 36 Cells from passages 2 to 6 were cultured in DMEM with 10% fetal bovine serum. Cell number and cell size were determined with a CASY cell counter system (CASY, Reutlingen, Germany).
Western Blot
Cells were lysed with Cell Signaling Technology lysis buffer (150 mmol/L NaCl, 10 mmol/L Tris [Base], pH 7.4, 1% Triton X-100, protease inhibitor cocktail I from Calbiochem, 1 mmol/L EDTA, and 184 mg/L sodium orthovanadate), and proteins were separated by 12% SDS-PAGE for ERK/phospho-ERK. Proteins were transferred to nitrocellulose and incubated overnight with anti-phospho-ERK or anti-ERK (1:1000, Cell Signaling Technology) respectively with anti-EGFR or anti-heat shock protein 90 (1:1000, Cell Signaling Technology) according to the manufacturer's protocol. Protein bands were detected by horseradish peroxidase-conjugated secondary antibody (anti-rabbit IgG, Biotrend, Cologne, Germany).
Determination of Cytosolic Ca

2؉
Cytosolic free calcium was determined using the Ca 2ϩ sensitive dye fura-2 (Molecular Probes, Leiden, the Netherlands) as described previously 37 with an inverted Zeiss 100 TV microscope (magnification ϫ400, oil immersion, Zeiss, Oberkochen, Germany) and an automatic filter change device (Hamamatsu, Herrsching, Germany). Cells were cultivated on glass coverslips, and serum was removed 24 hours before the measurements. Subsequently, cells were incubated for 15 minutes with 5 mol/L fura-2-AM. Finally, coverslips were transferred to the stage of the microscope. The fluorescence signal was monitored at 510 nm, with excitation wavelength alternating between 334 and 380 nm, using a 100-W xenon lamp (fura-2 ratio). The sampling rate was 1 ratio every 2 s. At the end of each experiment thapsigargin was applied as a positive control and only cells responding to thapsigargin were included for further analysis. We did not observe significant differences with respect to the thapsigargin response for the 3 genotypes. Stimulus-induced changes in Ca 2ϩ were accepted only if the induced change in the fura-2 ratio exceeded signal standard deviation of 10 preceding measurements by more than 4-fold. Thus, a cell was categorized as a responder if the Ca 2ϩ signal increased by more than 4 times the SD of the baseline signal before the addition of the stimulus. The percentage of responders was determined from the sum of all measurements under a certain experimental condition (number responding/number measured). The response behavior of the cells during the different measurements for a given condition was very similar, with a variance of 10% or less.
Real-Time Quantitative Polymerase Chain Reaction
RNA was isolated using the RNeasy Mini Kit from Qiagen (Hilden, Germany) according to the manufacturer's instructions. Subsequently, remaining DNA was digested with DNase I. Reverse transcription was performed with 1 g of RNA and random primers using qScript from Invitrogen according to the manufacturer's instructions. As a control, each sample was also analyzed without reverse transcription. The signals obtained without reverse transcription were negligible (Ͻ1%). Finally, real-time amplification was performed with the Stratagene Mx 3005P using the Platinum SYBR Green kit (Invitrogen) according to the manufacturer's instructions. Quantitative PCR (qPCR) efficiency was Ͼ90%. The relative expression of mRNA was calculated according to the 2 ⌬⌬Ct method, using the 18S signal for normalization. Each sample was analyzed in triplicate, as follows: EGFR sense primer, GACCTTCACATCCTGCCAGTEGFR; EGFR antisense primer, GCATGGAGGTCAGTCCAGTT; 18S sense primer, GTTGGTGGAGCCGATTTGTCTGG; 18S antisense primer, AGGGCAGGGACTTAATCAACGC. Annealing temperatures were 63°C and 64°C for EGFR and 18s, respectively.
Lactate Dehydrogenase Release
Lactate dehydrogenase (LDH) activity in media and in cell lysates was measured using a standard protocol 38 adapted to a lower scale (200 L) in a multiwell-multilabel reader (Infinite, Tecan, Berlin).
Caspase-3 Activity
Caspase-3 activity was measured as described previously. 38 Briefly, cells were washed once with PBS buffer (4°C) and incubated with 100 L of cell lysis buffer (10 mmol/L TRIS, 100 mmol/L NaCl, 1 mmol/L EDTA, 0.01% Triton X-100, pH 7.5) for 10 minutes on ice, harvested, and centrifuged at 16 000g for 10 minutes at 4°C. Sixty microliters of the supernatant was incubated with 65 L of reaction buffer (20 mmol/L piperazine-N,N=-bis(ethanesulfonic acid), 4 mmol/L EDTA, 0.2% CHAPS, 10 mmol/L dithiothreitol, pH 7.4) containing 42 mol/L DEVD-7-amino-4-trifluoromethylcoumarin (AFC) (end concentration) at 37°C, and fluorescence of the cleaved product, AFC, was measured at 400 nm excitation and 505 nm emission wavelength using a multiwell-multilabel counter (Infinite). Cleaved AFC was quantified by a calibration curve using known AFC concentrations. Protein content was determined with bicinchoninic acid assay (Interchim, Montluçon, France) using bovine serum albumin as a standard.
Glucose-6-Phosphate Dehydrogenase Activity
Glucose-6-phosphate dehydrogenase (G6PD) activity was measured as described by Leopold and Loscalzo. 39 Briefly, cells were washed with phosphate-buffered saline (0.9%), scraped from the plate, lysed, and centrifuged at 2000g at 4°C for 10 minutes. Enzyme activity was determined using a plate-reader spectrophotometer (Sunrise, Tecan, Crailsheim, Germany) by measuring the rate of increase of absorbance at 340 nm due to the conversion of NADP ϩ to NADPH by either G6PD or 6-phosphogluconate dehydrogenase (6-PGDH). To determine total dehydrogenase activity, we added 40 L of supernatant to a well that contained 160 L of assay buffer and substrates for both enzymes. In a second well, substrates for the enzyme 6-PGDH were added to determine the activity of this enzyme. G6PD activity was then determined by subtracting 6-PGDH activity from total dehydrogenase activity. Substrate concentrations were glucose-6-phosphate (200 mol/L), 6-phosphogluconate (200 mol/L), and NADP ϩ (100 mol/L). Protein levels were determined for each sample, and activity results were standardized to protein concentration.
Collagen-3 and Fibronectin ELISA
Extracellular collagen III and fibronectin were determined by ELISA as described previously. 40, 41 Media and collagen standards (SigmaAldrich, Deisenhofen, Germany) were incubated for 24 hours in 96-well Nunc-Immuno Maxisorp plates (Nalge Nunc International, Naperville, IL) followed by washing and blocking with 2% bovine serum albumin. Subsequently, the wells were incubated with rabbit antibody against collagen III or fibronectin (1:1000, Biotrend, Cologne, Germany) for 1 hour at room temperature. After another 3 washes with 0.05% Tween in phosphate-buffered saline, horseradish peroxidase-conjugated secondary antibody (1:5000, Biotrend, Cologne, Germany) was applied for 1 hour at room temperature. After 3 washes with 0.05% Tween in phosphate-buffered saline, the wells were incubated with o-phenlyenediamine (Sigma-Aldrich); the reaction was stopped after 15 minutes with 1 N H 2 SO 4 , and the absorbance was measured at 490 nm. Cellular protein was determined by the BCA assay from Pierce. We tested the cross-reactivity of the primary antibodies using the collagen standards and did not observe any significant cross-reactivity.
Immunofluorescence
Cells were cultivated on glass coverslips, fixed with 4% formaldehyde (15 minutes), washed 3 times with PBS, and permeabilized with 0.5% Triton X-100. Subsequently, cells were incubated for 10 minutes in 1% SDS/PBS, followed by 10 minutes of 100 mmol/L glycine/PBS, and finally incubated for 20 minutes in 10% serum/1% BSA/PBS. After 60 minutes of incubation with primary antibody, the cells were washed 3 times with PBS and incubated for 45 minutes with anti-rabbit Alexa 568 secondary antibody or nonlabeled secondary antibody. After 3 additional washes, the cells were analyzed by fluorescence microscopy (Biozero, Keyence, Osaka, Japan) and confocal microscopy (Radiance 2000, Bio-Rad).
Materials
Unless otherwise stated, all other materials were from Sigma-Aldrich 
Statistics
The data are presented as mean valuesϮSEM. Significance of difference was tested by paired or unpaired Student t test or ANOVA as applicable. Differences were considered significant if PϽ0.05. Cells from at least 3 mice per genotype, and 3 matching passages were used for each experimental series. Thus, all experiments were performed with cells from at least 3 different animals and 3 different passages. Cell from the 3 genotypes were treated in parallel for the various repetitions. N represents the number of cells or tissue culture dishes investigated.
Results
Basal Phenotype of EGFR
⌬/⌬ VSMC Animals EGFR ⌬/⌬ VSMC animals showed no differences in body weight, systolic blood pressure (measured by tail-cuff or intravasal), blood glucose, or hematocrit compared with EGFR ϩ/ϩ VSMC animals (Supplemental Table I , available online at http://atvb.ahajournals.org). Aortae and coronary vessels of EGFR ⌬/⌬ VSMC animals showed signs of dilative remodeling (reduced wall/lumen ratio) and slight fibrosis (Supplemental Table II ). Possible functional differences are currently under investigation (isolated aortic rings, in vivo reactivity to vasoactive substances) but were beyond the scope of the present study.
EGFR Expression and EGF Responsiveness
EGFR mRNA level was reduced to Ͻ10% in the aorta of EGFR ⌬/⌬ VSMC animals compared with EGFR ϩ/ϩ VSMC animals ( Figure 1A) Figure 1B ) and by Western blot ( Figure  1C ). Staining for ␣-smooth muscle actin was not affected. Loss of EGFR also reduced cell proliferation in the presence of 10% serum (ie, when non-EGF stimuli were present), emphasizing the central role of EGFR ( Figure 1D ). EGF responsiveness ( Figure 1E and 1F, incubation with 10 g/L EGF) with respect to ERK1/2 phosphorylation was completely absent in VSMC EGFRϪ/Ϫ . VSMC EGFRϩ/Ϫ showed a reduced response compared with VSMC EGFRϩ/ϩ . All 3 genotypes responded to phorbol-12-myristate-13-acetate (PMA) (protein kinase C [PKC] activation), which served as positive control, although the response was smaller in VSMC EGFRϩ/Ϫ and VSMC EGFRϪ/Ϫ compared with VSMC E -GFRϩ/ϩ ( Figure 1F ), suggesting that part of the effect of PKC on ERK1/2 phosphorylation is mediated by EGFR transactivation. 42 In VSMC EGFRϩ/ϩ , EGF elicited a slight and transient increase in cytosolic Ca 2ϩ , as indicated by the increase in the fura-2 ratio ( Figure 1G ). The Ca 2ϩ signal was similar in VSMC EGFRϩ/Ϫ but completely absent in VSMC EGFRϪ/Ϫ ( Figure 1G to 1I). These data support the conclusion that EGFR was successfully deleted.
Cell Survival and Metabolism
We measured parameters of cell survival and metabolism known to be relevant for VSMC pathophysiology. LDH release (normalized to total cellular LDH) was significantly higher in VSMC EGFRϪ/Ϫ (Figure 2) , indicating reduced viability. Furthermore, caspase-3 activity was elevated in VSMC EGFRϪ/Ϫ and VSMC EGFRϩ/Ϫ (Figure 2 ), indicating an enhanced basal apoptosis rate. Accordingly, protein content was reduced in VSMC EGFRϪ/Ϫ . G6PD activity (Figure 2 ), rate limiting for NAPDH homeostasis and therefore reactive oxygen species defense, was significantly lower in VSMC EGFRϪ/Ϫ . This was not the case for another enzyme of the pentose phosphate cycle, 6-PGDH (Figure 2 ), evidence of disturbed matrix homeostasis. mRNA levels for collagen III and fibronectin were also increased (Supplemental Table III ). Differences in cell size were not observed (mean diameter of VSMC EGFRϩ/ϩ 21.3Ϯ0.4 m, nϭ19). The responsiveness of these parameters to EGF was partially reduced in VSMC EGFRϩ/Ϫ and virtually abolished in VSMC EGFRϪ/Ϫ (Figure 2 ).
ET-1
ET-1, a ligand of the G-protein-coupled endothelin-1 receptors (ET A , ET B ), induced a significant stimulation of ERK1/2 phosphorylation in VSMC EGFRϩ/ϩ ( Figure 3A , 100 nmol/L ET-1 for 5 minutes). This response was significantly reduced in VSMC EGFRϩ/Ϫ and VSMC EGFRϪ/Ϫ ( Figure 3A) , although ET-1 elicited a significant ERK1/2 phosphorylation in VSMC EGFRϩ/Ϫ . These data support the hypothesis that ET-1 requires EGFR (transactivation) to activate ERK1/2 signaling. The functional relevance of this transactivation is indicated by the absence of a proliferative action of ET-1 in VSMC EGFRϪ/Ϫ in contrast to VSMC EGFRϩ/ϩ (Supplemental Table IV) .
ET A /ET B also couple to cellular Ca 2ϩ signaling and induce Ca 2ϩ release from cellular stores, as well as Ca 2ϩ entry via the plasma membrane. 43 To test whether EGFR transactivation also has an impact on Ca 2ϩ signaling, we compared ET-1-induced Ca 2ϩ responses in the 3 genotypes. Figure 3B shows the typical response of VSMC EGFRϩ/ϩ (meanϮSEM of 7 cells) with a rapid peak (resulting predominantly from Ca 2ϩ release from intracellular stores) and a subsequent plateau phase (resulting mainly from Ca 2ϩ entry from the extracellular space). We analyzed the increase in fura-2 ratio compared with the mean of 10 control values before the addition of ET-1 during the peak phase (⌬peak) as well as during the plateau phase (⌬plateau). In addition, we determined the relative number of cells responding to the stimulus (responders). As a positive control, we used 1 mol/L thapsigargin, an inhibitor of the endoplasmic Ca 2ϩ -ATPase, 44 and only cells showing an increase in intracellular Ca 2ϩ on thapsigargin application were included for further analysis. The percentage of total responders (ie, cells responding with either peak or plateau), as well as peak and plateau responders, was significantly higher in VSMC EGFRϩ/ϩ compared with the 2 other phenotypes ( Figure 3C ). Of 
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Characterization of VSMC From EGFR ⌬/⌬ VSMC Micenote, the percentage of peak responders was very low in VSMC EGFRϪ/Ϫ . There was no significant difference in ⌬peak or ⌬plateau when only the responders of the 3 genotypes were compared ( Figure 3C ). The time to peak (⌬t peak ) was not different for the 3 genotypes (50Ϯ3 seconds, Nϭ115). As shown in Figure 3D , there was no significant difference in the Ca 2ϩ response elicited by thapsigargin for the different genotypes, arguing against a general effect of EGFR knockout on basic cellular Ca 2ϩ handling.
Phenylephrine
Phenylephrine (PE), a ligand of the G-protein-coupled ␣ 1 -adrenergic receptor, induced a significant stimulation of ERK1/2 phosphorylation in VSMC EGFRϩ/ϩ ( Figure 4A , 1 mol/L PE for 5 minutes). This response was significantly reduced in VSMC EGFRϩ/Ϫ and VSMC EGFRϪ/Ϫ ( Figure 4A ), although PE still elicited a significant ERK1/2 phosphorylation compared with vehicle-treated cells. These data clearly support the hypothesis 12, 45 that the major part of ␣ 1 -adrenergic receptor-induced ERK1/2 phosphorylation requires EGFR (transactivation). The functional relevance of this transactivation is indicated by the absence of a proliferative action of PE in VSMC EGFRϪ/Ϫ in contrast to VSMC EGFRϩ/ϩ (Supplemental Table IV ). ␣ 1 -Adrenergic receptor also couples to cellular Ca 2ϩ signaling and induces Ca 2ϩ release from cellular stores, as well as Ca 2ϩ entry via the plasma membrane. 46 As shown in Figure 4B, Figure 4B ). These findings raised the question of whether the difference in the fraction of responsive cells is due to the acute role of EGFR in Ca 2ϩ signaling or results from altered developmental processes when EGFR is absent, possibly leading to a different expression pattern of Ca 2ϩ -handling proteins. Therefore, we performed experiments determining the fraction of responders to ET-1 or PE in wild-type VSMC with and without the EGFR-kinase inhibitor AG1478 (100 nmol/L, present during the 60 minutes of preincubation, as well as the time of hormone application, Nϭ58 to 101 for each condition). The fraction of responders to either hormone was not reduced in the presence of AG1478 (range, 92% to 98%), indicating that the probability of a Ca 2ϩ response does not depend on acute EGFR transactivation but results from altered gene expression or adaptive processes. A more detailed investigation regarding the processes leading to these differences when EGFR is absent will be performed in future studies.
ATP
ATP, a ligand of the G-protein-coupled purinergic receptors, induced a significant stimulation of ERK1/2 phosphorylation in VSMC EGFRϩ/ϩ ( Figure 5A , 10 mol/L ATP for 5 minutes). This response was significantly reduced in G-protein-coupled purinergic receptors also couple to cellular Ca 2ϩ signaling and induce Ca 2ϩ release from cellular stores, as well as Ca 2ϩ entry via the plasma membrane. 47 As shown in Figure 5B , the percentage of responders was not significantly different in VSMC EGFRϪ/Ϫ compared with VSMC EGFRϩ/ϩ (VSMC EGFRϩ/Ϫ were not tested). The percentage of VSMC EGFRϪ/Ϫ cells responding with a Ca 2ϩ peak was lower, although not statistically significant. ⌬Ca 2ϩ of responsive cells was larger in VSMC EGFRϪ/Ϫ compared with VSMC EGFRϩ/ϩ ( Figure 5B ). Thus, ATP-induced Ca 2ϩ signaling is modulated quantitatively by EGFR expression.
H 2 O 2
Exposure to the reactive oxygen species H 2 O 2 has been proposed to induce ERK1/2 phosphorylation as part of a cell protection response against radical stress. 12,48,49 As shown in Figure 6A, 
Discussion
Many studies on ErbB family functions focused on embryonic development, as well as cancer development. In recent years, however, ErbB1/EGFR has been studied more intensively with respect to its potential pathophysiological role for VSMC. It has been shown pharmacologically that several factors that are considered to be involved in vascular diseases transactivate EGFR and thereby initiate mitogen-activated protein kinase signaling. 51 Transactivation of EGFR was reported 15 years ago 52 and is now accepted as an important mechanism for signaling cross-talk that is essential to mediating critical functions of mediators and micromilieu parameters. 9 Thus, the mechanisms of EGFR transactivation, as well as its pathophysiological significance, are of major interest for vascular biology and medicine. EGFR transactivation seems to require intracellular second messenger activation, such as Ca 2ϩ , PKC, or the generation of reactive oxygen species. Subsequently, cytosolic nonreceptor tyrosine kinase such as Src or protein tyrosine kinase-2 may phosphorylate and transactivate EGFR. Alternatively, transactivation is accomplished by metalloprotease-dependent EGFR/ ErbB ligand production from its membrane-bound proform. 53 HB-EGF is a ligand with strong implications in vascular diseases. HB-EGF can stimulate growth and migration of VSMCs and is expressed in pathological vascular states such as atherosclerosis and restenosis after angioplasty. 51 In addition to HB-EGF and ErbB1/EGFR, other combinations of ErbB ligand-receptor complexes can also be activated by A 
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Characterization of VSMC From EGFR ⌬/⌬ VSMC Micedisintegrin and metalloproteinase-dependent shedding of ErbB ligands, leading to diverse arrays of downstream signal transduction pathways with potential relevance for vascular remodeling. These findings implicate EGFR as an element of signaling convergence by which various vascular risk factors promote vascular remodeling. 6 Beyond that, the physiological significance of vascular EGFR expression and signaling is not known. Therefore, we currently do not know whether there is a yin-yang situation with respect to vascular EGFR, which might contribute to basic vascular homeostasis but could also be subject to "misuse" under certain pathophysiological conditions. In the present study, we investigated the consequence of cell-specific EGFR deletion in VSMC of mice with respect to the basal phenotype and signaling. Because general EGFR-knockout animals are not viable after birth, 54 this model for the first time allows genetic testing of the importance of VSMC EGFR.
Our data show, first of all, that although VSMC EGFR had been successfully deleted (in liver cells EGFR expression was not different from wild-type animals), the animals are viable for several weeks after birth. However, aorta and coronary arteries from EGFR ⌬/⌬ VSMC animals showed signs of dilative remodeling (reduced wall/lumen ratio) and slight fibrosis (enhanced collagen III mRNA and Sirius red staining). The morphological data on the vascular phenotype require further experimentation to obtain mechanistic insights and draw conclusion regarding the pathomechanisms and their consequences. At present we cannot exclude the possibility that the changes in wall/lumen ratio are in part the result of different vessel contraction at the time of fixation.
Further detailed phenotyping of the animals and isolated aortae is currently in progress. Net growth of VSMC EGFRϪ/Ϫ was slower, as shown by the growth curve ( Figure 1D ), and the lower protein amount per cm 2 in the Petri dish after 10 days (Figure 2 ), despite the same starting cell number and no major differences in cell size. The reduced net growth rate is in part due to an enhanced death rate, as indicated by the higher LDH release (necrosis) and caspase-3 activity (apoptosis). Because EGF reduced LDH release (antinecrotic effect) in VSMC EGFRϩ/ϩ and VSMC EGFRϩ/Ϫ , we conclude that the EGFR exerts a cytoprotective action in VSMC. Surprisingly, EGF did not affect caspase-3 activity in any of the 3 genotypes. Possibly, the antiapoptotic action of EGFR depends on the activation by other ligands or on transactivation. Cytoprotection by EGFR can be explained in part by the reduced pentose phosphate pathway activity (reduced G6PDH activity in VSMC EGFRϪ/Ϫ ). G6PD hydrogenase (H), which is known to be stimulated by EGF, 55, 56 is the rate limiting enzyme of the pentose phosphate pathway supplying the cell with NADPH, an important intracellular reducing equivalent to protect against oxidative injury and a cofactor for nitric oxide synthase as well as for lipogenesis. In addition, this pathway supplies the cells with ribose 5-phosphate for nucleic acid synthesis. We assume that impaired protection against oxidative injury is the most probable explanation for enhanced cell death in VSMC E -GFRϪ/Ϫ. A nonspecific reduction in G6PDH activity can be excluded, as the activity of 6-PGDH ( Figure 2 ) and cellular LDH (data not shown) were not significantly different from that of wild-type cells. VSMC EGFRϪ/Ϫ showed an enhanced rate of extracellular collagen III and fibronectin accumulation, indicating an important role for EGFR in the control of basal matrix homeostasis. This conclusion is supported by the inhibitory effect of EGF on collagen III and fibronectin accumulation in VSMC EGFRϩ/ϩ . Thus, EGFR prevents excessive matrix deposition under physiological conditions, contributing to vascular wall tissue homeostasis. In VSMC EGFRϩ/Ϫ collagen III and fibronectin accumulation was significantly lower compared with VSMC EGFRϩ/ϩ , indicating a biphasic effect of EGFR on matrix homeostasis: low levels of EGFR are associated with a minimum of matrix deposition, which increases dramatically in the absence of EGFR but also rises when EGFR expression is elevated. This relation could explain why pathophysiological EGFR transactivation may contribute to vascular remodeling. Surprisingly, VSMC EGFRϪ/Ϫ responded to EGF with a partial reduction in collagen III accumulation. One explanation for this EGF responsiveness is the presence of ErbB-2/ErbB-3 heterodimers with high affinity for EGF, 57, 58 comparable to EGFR. By qPCR analysis, ErbB-2 and -3 were detected in all 3 genotypes at comparable levels, whereas ErbB-4 was below the detection limit (data not shown). Of note, fibronectin accumulation of VSMC EGFRϪ/Ϫ did not respond to EGF, suggesting the existence of different EGF signaling pathways for the regulation of matrix homeostasis. Of course, this hypothesis awaits further testing in future studies. In summary, EGFR seems to play an important role for the maintenance of physiological cell and vascular tissue homeostasis, ie, exerts a beneficial vascular effect.
Our data on ERK1/2 phosphorylation show that EGFR contributes substantially to the effects of ET-1, ␣ 1 -adrenergic agonists (PE), ATP, reactive oxygen species (H 2 O 2 ), and protein kinase C activation (PMA), supporting the concept of EGFR transactivation. ET-1, ␣ 1 -adrenergic agonists, and PKC activation seem to be more dependent on EGFR because their effect was also significantly reduced in VSMC EGFRϩ/Ϫ . This was not the case for ATP and H 2 O 2 , although there was a tendency for reduced ERK1/2 phosphorylation in VSMC EGFRϩ/Ϫ . The proliferative action of ET-1 and ␣ 1 -adrenergic agonists was completely abrogated in VSMC EGFRϪ/Ϫ , confirming the functional relevance of EGFR transactivation.
The effect of H 2 O 2 or ATP on cytosolic Ca 2ϩ was not reduced by the absence of EGFR. On the contrary, the changes in cytosolic Ca 2ϩ were higher in the absence of EGFR, suggesting a negative feedback loop involving EGFR. ET-1-and PE-induced responsiveness of Ca 2ϩ signaling was affected by the EGFR genotype. In the case of ET-1, EGFR expression influenced the percentage of responsive cells, which was Ϸ90% in VSMC EGFRϩ/ϩ . Because only cells responding to thapsigargin were included in the analysis and the percentage was also reduced in VSMC EGFRϩ/Ϫ , we can exclude a nonspecific effect of reduced cell viability. Although the immunoblot data contain no evidence for a residual EGFR expression in knockout cells, there remains the possibility for a subthreshold amount of EGFR in few cells, because by qPCR a residual amount of mRNA (less than 10%) was detected. At present, it is not possible to distinguish experimentally between a small "contamination" of the primary culture with non-VSMC and a small residual amount of EGFR in VSMC. However, the fraction should be very small, as we did not observe EGF-sensitive knockout cells with respect to calcium signaling ( Figure 1H ). Possible EGFR-positive cells are not sufficient to explain the fraction of responders to PE or ET-1.
When the Ca 2ϩ signals of ET-1-responsive cells were compared, no significant differences were observed. The percentage of PE-responsive cells was reduced only in VSMC EGFRϪ/Ϫ . However, the Ca 2ϩ signals of PE-responsive cells were enhanced in VSMC EGFRϩ/Ϫ and VSMC EGFRϪ/Ϫ compared with VSMC EGFRϩ/ϩ , also suggesting a negative feedback loop involving EGFR. At present, we have no proven explanation for the mechanisms behind this difference in Ca 2ϩ signaling. The mechanism seems to have certain specificity, because Ca 2ϩ handling was affected differently. An acute functional role of EGFR in Ca 2ϩ signaling, as well as altered expression of Ca 2ϩ -handling proteins, is conceivable. As the fraction of responders was not reduced by the acute addition of the EGFR inhibitor AG1478, we favor the hypothesis that the probability of a Ca 2ϩ response does not depend on acute EGFR transactivation but results from altered gene expression or adaptive processes. Future studies will have to address this question in more detail.
Preliminary organ bath experiments with aortic ring preparations indicate that isometric force development during ␣ 1 -adrenergic stimulation is enhanced after repetitive hormone application in VSMC EGFRϪ/Ϫ compared with VSMC EGFRϩ/ϩ (data not shown). Thus, the larger Ca 2ϩ response may result in enhanced vasoconstrictor sensitivity and finally in augmented peripheral resistance, although altered receptor handling (ie, desensitization) cannot be excluded. On the other hand, with respect to the functional vascular relevance, it might be more relevant to consider the integrated calcium signal composed of the probability of a calcium signal (P R ϭfraction of responders) and the magnitude of the signal (⌬Ca 2ϩ ). The resulting integrated or average-and probably relevant for a vessel-signal is the product P R ϫ⌬Ca 2ϩ . With respect to PE and ET-1, this average signal is lower in knockout cells compared with wild-type (compare P R and ⌬Ca 2ϩ in Figures 3C and 4B ). Thus, from the integrated perspective, the data indicate a positive role for EGFR in mediating calcium signals, as also suggested for ang II signaling in afferent arterioles. 33 These hypotheses deserve more detailed investigation in the future.
In summary, our data confirm the importance of EGFR for ERK1/2 activation by a variety of unrelated stimuli. Furthermore, our data show that EGFR expression has a heterologous signaling role beyond mitogen-activated protein kinase activation and can modulate Ca 2ϩ signaling. VSMC EGFR seems to be Janus-faced. Its absence makes cells more vulnerable and disturbs matrix homeostasis, leading to dilative remodeling. Overstimulation, on the contrary, promotes vascular fibrotic remodeling, as suggested by various reports in the literature. The model presented here offers the possibility to assess the contribution of VSMC EGFR to vascular remodeling induced by a variety of factors known to transactivate the EGFR.
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